LICNNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Lichen International Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$0.86+0.00 (+0.01%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Gross margin
1129.4%+1068.0 pts over 5 years
Operating margin
-2233.5%−2262.2 pts over 5 years
Net margin
-2714.7%−2735.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | – | -71.2% | -51.7% | – | |
| Gross profit | -64.4% | -23.2% | -13.5% | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 24.9% | -30.6% | |
| Return on assets | – | – | -28.3% | |
| Current ratio | – | – | 7.73 | |
| Inventory turnover | – | – | -248.6× | |
| Capex to revenue | – | – | 0.0% | |
| Diluted shares | – | 0M | 5M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Lichen International generated $42.05M from operations and spent $5.22M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$42.05M
Used
$5.22M
Capital expenditure$5.22M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-2714.7%
×Asset turnover0.01×
×Equity multiplier1.08×
=Return on equity, FY2025-30.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -2714.7% | 0.01× | 1.08× | -30.6% |
| FY2022 | 23.1% | 0.76× | 1.15× | 20.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$21.96M
- Cash generatingOperating cash flow above zero-$17.85M
- Return on assets improvedROA up on the prior year-9.4% → -27.5%
- Earnings backed by cashOperating cash flow above net income-$17.85M vs -$21.96M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose7.96 → 7.73
- No dilutionShare count did not rise0M → 5M
- Gross margin improvedGross margin up on the prior year– → 1129.42%
- More efficientAsset turnover rose0.00 → 0.01